Pennsylvanian doctors are weighing in on Journavx, a newly approved painkiller that’s said to be free of addiction risks. Pittsburgh Regional Transit is looking for more funding. Philadelphia’s first major, post-pandemic office-to-apartment conversion project is almost done. Lastly, as Paul Revere would say: The cicadas are coming.